Multi-Drug Resistant Gram-Negative Sepsis in Neonates: The Special Role of Ceftazidime/Avibactam and Ceftolozane/Tazobactam. [PDF]
Dermitzaki N +6 more
europepmc +1 more source
Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR <i>Pseudomonas</i> <i>aeruginosa</i> (PUMA). [PDF]
Lodise TP +3 more
europepmc +1 more source
Pharmacodynamic Comparison of Ceftolozane/Tazobactam and Ceftazidime/Avibactam, Administered by Intermittent or Continuous Infusion, Against a Clinical Isolate of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Producing GES <i>β</i>-Lactamase in a Hollow Fiber Infection Model. [PDF]
Ahn TK +6 more
europepmc +1 more source
Rapid valve sterilization with meropenem plus ceftolozane/tazobactam combination therapy for <i>Pseudomonas aeruginosa</i> prosthetic valve endocarditis. [PDF]
Alaguvel V +9 more
europepmc +1 more source
Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns. [PDF]
Olivet JD +8 more
europepmc +1 more source
A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant <i>Pseudomonas aeruginosa</i> infections. [PDF]
Collings H +6 more
europepmc +1 more source
The synergistic effect between phages and Ceftolozane/Tazobactam in Pseudomonas aeruginosa endotracheal tube biofilm. [PDF]
Oliveira VC +6 more
europepmc +1 more source
Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in <i>Pseudomonas aeruginosa</i> isolates in a tertiary hospital. [PDF]
Imeneo A +12 more
europepmc +1 more source

